Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MC2-25 cream versus placebo for chronic kidney disease-associated pruritus
ISRCTN74524864Phase 2Completed
- Sponsor
- MC2 Therapeutics
- Start
- Apr 2022
- Modality
- Peptides
01
Overview
Phase 2, randomised, double-blind trial in chronic kidney disease (CKD) comparing MC2-25 cream with Vehicle placebo (2 arms). Primary endpoint: Weekly mean WI-NRS from Baseline to Week 12. Started Apr 2022; status: completed.
02
Drugs
MC2-25
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ISRCTN74524864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN74524864.